News
Article
Pharmaceutical Technology
Pharmaceutical Technology-09-02-2004Volume28 Issue 9
Promoting Quality in Drug Manufacturing
Author(s):
FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
